---
title: 'Research Daily Summary: What Happened on November 14, 2026'
headline: Blood marker distinguishes advanced CTE in preliminary study
description: The findings point to a possible way to detect severe disease, but the
  marker is not validated for CTE diagnosis.
url: https://thebench.bio/news/research/2026-11-14
topic: research
date: '2026-11-14'
covers:
- '2026-11-14'
date_published: '2026-11-14T12:01:33Z'
date_modified: '2026-11-15T00:01:17Z'
tags:
- Research
sources: 1
publisher: TheBench.Bio
---

# Research Daily Summary: What Happened on November 14, 2026

**Blood marker distinguishes advanced CTE in preliminary study**

The findings point to a possible way to detect severe disease, but the marker is not validated for CTE diagnosis.

## Today in brief

Washington University researchers found that blood levels of eMTBR-tau243 rose with CTE severity and separated advanced cases from controls with an AUC of 0.97. [1] The preliminary study found lower accuracy for stage I CTE, and the marker alone cannot distinguish CTE from Alzheimer’s disease. [1]

## Sources

1. [Blood Biomarker Shows Promise for Detecting Advanced Chronic Traumatic Encephalopathy](<https://www.insideprecisionmedicine.com/topics/molecular-dx/blood-biomarker-shows-promise-for-detecting-advanced-chronic-traumatic-encephalopathy/>), Inside Precision Medicine, 2026-11-14

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://www.insideprecisionmedicine.com/topics/molecular-dx/blood-biomarker-shows-promise-for-detecting-advanced-chronic-traumatic-encephalopathy/>
